Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

Clinical trials sponsored by Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company, explained in plain language.

Not yet finished but already full! 1

Radioactive therapy targets tough prostate cancers in major trial

Disease control Ongoing

This phase 3 trial tests a radioactive drug called Lu-177-PNT2002 in 455 men with metastatic castration-resistant prostate cancer that has worsened after hormone therapy. The drug seeks out and delivers radiation directly to cancer cells. The main goal is to see if it delays canc…

Phase: PHASE3 • Sponsor: POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC